Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Y008483 | — |
No additional AE cases; T/E for VAQTA that was administered; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-FEB-2025, there was a temperature excursion of Hepatitis A Vaccine, Inactivated (VAQTA) with 32.0°F during 2 hours 12 minutes 0 seconds. Then on 03-Mar-2025, the patient was vaccinated with that dose (second dose) of Hepatitis A Vaccine, Inactivated (VAQTA) lot #Y008483, expiration date: 26-Nov-2025 (strength, dose, route and anatomical location were not provided) for prophylaxis. There was no previous temperature excursion. No adverse events reported.